Risk stratifying acute coronary syndromes: Gradient of risk and benefit
- 1 July 1999
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 138 (1) , s6-s11
- https://doi.org/10.1053/hj.1999.v138.99081
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC studyAmerican Heart Journal, 1998
- Applicability of Cardiac Troponin T and I for Early Risk Stratification in Unstable Coronary Artery DiseaseCirculation, 1997
- Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein graftsThe American Journal of Cardiology, 1997
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery DiseaseCirculation, 1996
- Incidence and follow-up of Braunwald subgroups in unstable angina pectorisJournal of the American College of Cardiology, 1995
- Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.Circulation, 1994
- The Prognostic Value of Serum Troponin T in Unstable AnginaNew England Journal of Medicine, 1992
- Unstable angina. A classification.Circulation, 1989